
BACKGROUND:Chlamydia abortus, as a pathogen of atypical pneumonia, is rare in humans, especially in HIV infection patients. CASE PRESENTATION:We present the case of a 48-year-old man with a history of HIV infection who started high fever and developed pneumonia. The pathogen-targeted next-generation sequencing (ptNGS) results of bronchial lavage fluid showed Chlamydia abortus infection. CONCLUSION:This is the first report of Chlamydia abortus infection presented as atypical pneumonia in an AIDS patient.
The dissemination of carbapenem-resistant Gram-negative bacilli (CRGNB) is a global public health issue. CRGNB isolates are usually extensively drug-resistant or pandrugresistant, resulting in limited antimicrobial treatment options and high mortality. A multidisciplinary guideline development group covering clinical infectious diseases, clinical microbiology, clinical pharmacology, infection control, and guideline methodology experts jointly developed the present clinical practice guidelines based on best available scientific evidence to address the clinical issues regarding laboratory testing, antimicrobial therapy, and prevention of CRGNB infections. This guideline focuses on carbapenem-resistant Enterobacteriales (CRE), carbapenem-resistant Acinetobacter baumannii (CRAB), and carbapenem-resistant Pseudomonas aeruginosa (CRPA). Sixteen clinical questions were proposed from the perspective of current clinical practice and translated into research questions using PICO (population, intervention, comparator, and outcomes) format to collect and synthesize relevant evidence to inform corresponding recommendations. The grading of recommendations, assessment, development and evaluation (GRADE) approach was used to evaluate the quality of evidence, benefit and risk profile of corresponding interventions and formulate recommendations or suggestions. Evidence extracted from systematic reviews and randomized controlled trials (RCTs) was considered preferentially for treatment-related clinical questions. Observational studies, non-controlled studies, and expert opinions were considered as supplementary evidence in the absence of RCTs. The strength of recommendations was classified as strong or conditional (weak). The evidence informing recommendations derives from studies worldwide, while the implementation suggestions combined the Chinese experience. The target audience of this guideline is clinician and related professionals involved in management of infectious diseases. Copyright 2023, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
目的 分析海南省人民医院临床使用伏立康唑致肝损伤的发生情况,探索可能的影响因素.方法 将研究期间使用伏立康唑并接受血药浓度监测且起始肝功能正常的患者纳入研究,根据用药后肝功能检查结果将患者分为未发生肝损伤组和发生肝损伤组.采用单因素及二元logistic回归分析伏立康唑致肝损伤的危险因素,并使用受试者工作特征(ROC)曲线确定各个危险因素预测性能的灵敏度、特异度和最佳截点.结果 共有 116 例患者纳入研究,肝损伤发生率为 28.4%.单因素和多因素分析结果显示血药谷浓度及感染指标C反应蛋白(CRP)是伏立康唑致肝损伤的危险因素,血药谷浓度>4.80 mg/L及CRP>127.86 mg/L的患者肝损伤风险显著增加.结论 对于CRP较高的患者使用伏立康唑期间应当密切监测血药浓度以降低肝损伤风险.
Objective To investigate the distribution and antimicrobial resistance of the potential pathogens isolated from pharyngeal swabs of hematopoietic stem cell transplantation(HSCT) recipients. Methods A total of 1 476 consecutive patients who underwent HSCT in the First Affiliated Hospital of Soochow University from January 1, 2018 to December 31, 2020 were enrolled. Pharyngeal swab was taken every week starting from the first day after admission to transplant wards until discharge. The detection rate, distribution,and antimicrobial resistance of the pathogens isolated from pharyngeal swabs were compared between allogeneic transplantation recipients and autologous transplantation recipients retrospectively. Results Overall, 176 strains of pathogens were isolated from 176 of the 1 476 HSCT recipients by pharyngeal swabs. The detection rate was 11.92%. Most(93.18%, 164/176) of the isolates were Gram-negative bacteria, including Enterobacteriaceae and non-fermenting Gram-negative bacteria. The top five species were Klebsiella pneumoniae(23.30%, 41/176), Stenotrophomonas maltophilia(21.59%, 38/176), Burkholderia cepacia(15.91%, 28/176), Enterobacter cloacae(10.80%, 19/176), and Acinetobacter baumannii(9.66%, 17/176). There were 12(6.82%) strains of Gram-positive bacteria, including Staphylococcus aureus(3.98%, 7/176) and Staphylococcus epidermidis(1.70%, 3/176). Antimicrobial susceptibility testing showed that more than 50% of K. pneumoniae and E. cloacae isolates were resistant to ampicillin, piperacillin, ceftriaxone, levofloxacin and cotrimoxazole, while less than 20% of the isolates were resistant to imipenem. Not more than 40% of S. maltophilia and B. cepacia isolates were resistant to cefoperazone-sulbactam, ceftazidime, levofloxacin, trimethoprim-sulfamethoxazole, or minocycline. About 40% of A. baumannii strains were resistant to ceftriaxone, less than 30% resistant to cefoperazone-sulbactam, nearly 10% resistant to amikacin, and higher than 70% resistant to imipenem. The detection rate, distribution and antimicrobial resistance of Gram-negative bacteria did not show significant difference between allogeneic transplantation recipients and autologous transplantation recipients(P > 0.05). Conclusions Pharyngeal swab culture during hematopoietic stem cell transplantation is conducive to screening potential pharyngeal pathogens, which can inform the rational use of antibiotics and effective prevention and treatment of infections.
1 前言 碳青霉烯类抗菌药物包括亚胺培南、美罗培南和厄他培南等,是治疗多重耐药革兰阴性菌所致感染最有效的抗菌药物之一.随着该类药物在临床的广泛使用,碳青霉烯类耐药细菌(carbapenem-resistant organisms, CRO)的检出率呈逐年上升趋势,其中以肺炎克雷伯菌、铜绿假单胞菌和鲍曼不动杆菌为代表.CHINET中国细菌耐药监测网2021年监测结果显示,我国临床分离肺炎克雷伯菌、铜绿假单胞菌和鲍曼不动杆菌对亚胺培南的耐药率分别为23.1%、23%和71.5%[1-2].